Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5.8S ribosomal RNA pseudogene 2 is a non-functional, paralogous sequence derived from the canonical 5.8S ribosomal RNA gene that resides within the nuclear ribosomal DNA array[1][3]. Pseudogenes of the 5.8S rRNA are characterized by sequence variability, lower guanine-cytosine content, insertions, deletions, and substitutions at evolutionarily conserved sites compared to the functional 5.8S rRNA gene[1][3]. These pseudogenes do not encode functional ribosomal components and are absent from mature ribosomes. They can coexist in the genome alongside the functional 5.8S rRNA genes, but their expression does not contribute to ribosome structure or protein synthesis[1]. While they may serve as technical markers in phylogenetic or taxonomic studies, they are not biological targets in the sense of receptors, enzymes, or drug targets, nor are they directly implicated in disease processes or therapeutic intervention[1][3]. Key considerations: - Not a therapeutic or biologically active target: It is not a receptor, enzyme, channel, or druggable entity; thus, it is not valid as a molecular target in pharmacology or therapeutics. - Pseudogene status: Its primary relevance lies in evolutionary studies, classification, and occasionally as a potential confounding factor in ribosomal DNA-based laboratory assays[1][3]. - No known functional, diagnostic, or therapeutic role: There are no interacting drugs, mechanisms of action, or safety concerns specifically tied to this pseudogene[1][3]. If you intended a functional ribosomal RNA gene, not a pseudogene, you may instead want the canonical 5.8S ribosomal RNA. The submitted name specifically refers to a pseudogene version, which is not a proper biological target, and this constitutes the main issue with this entity as a target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5.8S ribosomal RNA pseudogene 2 (RNA5-8SP2).